Publications

Duffy N, Koirala A, Williams PC. Epidemiology and outcomes of culture-proven neonatal meningitis in Australian Tertiary hospitals: a multicenter retrospective cohort study. Pediatric Infectious Disease Journal 2026. doi: 10.1097/INF.0000000000005131 (Epub). [Full text]

Hobbs M, Marek L, Wiki J, Paynter J, Nghiem N, Liu B, McIntyre P.. Examining spatial variation and inequity in COVID-19 immunisation coverage in Aotearoa New Zealand: a nationwide geospatial study. . Vaccine 2026;74:128165. doi: 10.1016/j.vaccine.2025.128165 (Epub). [Full text]

Brotherton JM, LaMontagne DS, Bloem PJ. Global status of HPV vaccination two decades in: effective, safe and preventing cancer. Expert Review of Vaccines 2026;25:2609869. doi: 10.1080/14760584.2025.2609869 (Epub). [Full text]

Simpson A, Hendry AJ, Macartney K, Beard FH. Uptake of Shingrix vaccine in its first year on the National Immunisation Program: an analysis of Australian Immunisation Register data. Public Health Research and Practice. 2026;36:PU25044. doi: 10.1071/PU25044 (Epub). [Full text]

Kaufman J, Steffens MS, Vidmar S, Bolsewicz KT, Leask J, Christou-Ergos M, Sabahelzain M, Boxall J, Danchin M. Association of access and acceptance barriers with under- and non-vaccination of children <5 years in Australia: a national cross-sectional survey of parents. Public Health 2026;250:106082. doi: 10.1016/j.puhe.2025.106082 (Epub). [Full text]

Blyth CC, Wadia U, Britton PN, Carr J, Clark JE, Crawford NW, Hung TY, Macartney KK, Marshall HS, Wood NJ, Kotsimbos T, Kelly PM, Cheng AC; FluCAN-PAEDS network.. Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS). Euro Surveillence 2026;31:2500275. doi: 10.2807/1560-7917.ES.2026.31.2.2500275. [Full text]

Carter N, Soe P, Deng L, Young J, King C, Quinn H, Macartney K, Bettinger JA, Wood N. Electronic, self-reported active vaccine safety surveillance: a three-country comparison of AusVaxSafety (Australia), CANVAS (Canada) and V-safe (United States). Human Vaccines & Immunotherapeutics 2025;21:2600189. doi: 10.1080/21645515.2025.2600189 (Epub). [Full text]

Homaira N, Qian J, Scaria A, Stepien S, Macartney K, Liu B. Effectiveness of maternal influenza vaccination on influenza and acute respiratory infection in infants. Pediatric Infectious Disease Journal 2025. doi: 10.1097/INF.0000000000005111 (Epub). [Full text]

Zhang X, Chen S, Tang S. Closing the immunization gap: overcoming barriers for new vaccine introduction in Southeast and South Asia. Vaccine 2025;72:128119. doi: 10.1016/j.vaccine.2025.128119 (Epub). [Full text]

Le H, Blyth CC, Schlegel C, Morgan JA, Mitrou F, Nguyen H, Foong R, Carlson S, Hughes C, Liu B, Moore HC. Socio-economic inequality underpins inequity in influenza vaccination uptake between public and private secondary schools: an Australian population-based study. Lancet Regional Health Western Pacific 2025;65:101761. doi: 10.1016/j.lanwpc.2025.101761. [Full text]